Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP781223.RAlD4B8ZkQRI9QE4y0FjmYZF4fnzqK_DmNdGys0s_MTtk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP781223.RAlD4B8ZkQRI9QE4y0FjmYZF4fnzqK_DmNdGys0s_MTtk130_assertion type Assertion NP781223.RAlD4B8ZkQRI9QE4y0FjmYZF4fnzqK_DmNdGys0s_MTtk130_head.
- NP781223.RAlD4B8ZkQRI9QE4y0FjmYZF4fnzqK_DmNdGys0s_MTtk130_assertion description "[Semiquantitative reverse transcriptase-PCR of genes involved in drug response, such as topoisomerase I, topoisomerase IIalpha, multidrug resistance 1 (MDR1), multidrug resistance-associated protein (MRP), lung resistance-related protein (LRP), and glutathione S-transferase pi (GSTpi), did not explain the variability in drug sensitivity between SCLC xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781223.RAlD4B8ZkQRI9QE4y0FjmYZF4fnzqK_DmNdGys0s_MTtk130_provenance.
- NP781223.RAlD4B8ZkQRI9QE4y0FjmYZF4fnzqK_DmNdGys0s_MTtk130_assertion evidence source_evidence_literature NP781223.RAlD4B8ZkQRI9QE4y0FjmYZF4fnzqK_DmNdGys0s_MTtk130_provenance.
- NP781223.RAlD4B8ZkQRI9QE4y0FjmYZF4fnzqK_DmNdGys0s_MTtk130_assertion SIO_000772 19823076 NP781223.RAlD4B8ZkQRI9QE4y0FjmYZF4fnzqK_DmNdGys0s_MTtk130_provenance.
- NP781223.RAlD4B8ZkQRI9QE4y0FjmYZF4fnzqK_DmNdGys0s_MTtk130_assertion wasDerivedFrom befree-20140225 NP781223.RAlD4B8ZkQRI9QE4y0FjmYZF4fnzqK_DmNdGys0s_MTtk130_provenance.
- NP781223.RAlD4B8ZkQRI9QE4y0FjmYZF4fnzqK_DmNdGys0s_MTtk130_assertion wasGeneratedBy ECO_0000203 NP781223.RAlD4B8ZkQRI9QE4y0FjmYZF4fnzqK_DmNdGys0s_MTtk130_provenance.